Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 1395

Similar articles for PubMed (Select 17570208)

1.

Increased regulatory T cells correlate with CD8 T-cell impairment and poor survival in hepatocellular carcinoma patients.

Fu J, Xu D, Liu Z, Shi M, Zhao P, Fu B, Zhang Z, Yang H, Zhang H, Zhou C, Yao J, Jin L, Wang H, Yang Y, Fu YX, Wang FS.

Gastroenterology. 2007 Jun;132(7):2328-39. Epub 2007 Apr 14.

PMID:
17570208
2.

PTPROt maintains T cell immunity in the microenvironment of hepatocellular carcinoma.

Hou J, Deng L, Zhuo H, Lin Z, Chen Y, Jiang R, Chen D, Zhang X, Huang X, Sun B.

J Mol Cell Biol. 2015 Jun 27. pii: mjv047. [Epub ahead of print]

3.

Upregulation of CD200 is associated with regulatory T cell expansion and disease progression in multiple myeloma.

Aref S, Azmy E, El-Gilany AH.

Hematol Oncol. 2015 Jun 1. doi: 10.1002/hon.2206. [Epub ahead of print]

PMID:
26033514
4.

Inflammatory models drastically alter tumor growth and the immune microenvironment in hepatocellular carcinoma.

Markowitz GJ, Michelotti GA, Diehl AM, Wang XF.

Sci Bull (Beijing). 2015 Apr 1;60(8):762-772.

5.

The functional and prognostic implications of regulatory T cells in colorectal carcinoma.

Zhang X, Kelaria S, Kerstetter J, Wang J.

J Gastrointest Oncol. 2015 Jun;6(3):307-13. doi: 10.3978/j.issn.2078-6891.2015.017. Review.

6.

Frequency, suppressive capacity, recruitment and induction mechanisms of regulatory T cells in sinonasal squamous cell carcinoma and nasal inverted papilloma.

Lou H, Fang J, Li P, Zhou W, Wang Y, Fan E, Li Y, Wang H, Liu Z, Xiao L, Wang C, Zhang L.

PLoS One. 2015 May 28;10(5):e0126463. doi: 10.1371/journal.pone.0126463. eCollection 2015.

7.

Immunological analysis of a patient with hepatitis B virus (HBV) reactivation after bone marrow transplantation.

Kowazaki Y, Osawa Y, Imamura J, Ohashi K, Sakamaki H, Kimura K.

Intern Med. 2015;54(10):1213-7. doi: 10.2169/internalmedicine.54.3706. Epub 2015 May 15.

8.

Dendritic cells transfected with heat-shock protein 70 messenger RNA for patients with hepatitis C virus-related hepatocellular carcinoma: a phase 1 dose escalation clinical trial.

Maeda Y, Yoshimura K, Matsui H, Shindo Y, Tamesa T, Tokumitsu Y, Hashimoto N, Tokuhisa Y, Sakamoto K, Sakai K, Suehiro Y, Hinoda Y, Tamada K, Yoshino S, Hazama S, Oka M.

Cancer Immunol Immunother. 2015 May 16. [Epub ahead of print]

PMID:
25982372
9.

Osthole promotes anti-tumor immune responses in tumor-bearing mice with hepatocellular carcinoma.

Zhang L, Jiang G, Yao F, Liang G, Wang F, Xu H, Wu Y, Yu X, Liu H.

Immunopharmacol Immunotoxicol. 2015 Jun;37(3):301-7. doi: 10.3109/08923973.2015.1035391. Epub 2015 May 15.

PMID:
25975579
10.

CD4+ and CD8+ T cells have opposing roles in breast cancer progression and outcome.

Huang Y, Ma C, Zhang Q, Ye J, Wang F, Zhang Y, Hunborg P, Varvares MA, Hoft DF, Hsueh EC, Peng G.

Oncotarget. 2015 Apr 29. [Epub ahead of print]

11.

Quantification of tumor infiltrating Foxp3+ regulatory T cells enables the identification of high-risk patients for developing synchronous cancers over upper aerodigestive tract.

Wang WL, Chang WL, Yang HB, Chang IW, Lee CT, Chang CY, Lin JT, Sheu BS.

Oral Oncol. 2015 Jul;51(7):698-703. doi: 10.1016/j.oraloncology.2015.04.015. Epub 2015 May 7.

PMID:
25958829
12.

Differential regulation and function of tumor-infiltrating T cells in different stages of breast cancer patients.

Zhu S, Lin J, Qiao G, Xu Y, Zou H.

Tumour Biol. 2015 May 8. [Epub ahead of print]

PMID:
25953262
13.

LncRNA HULC affects the differentiation of Treg in HBV-related liver cirrhosis.

Zhao J, Fan Y, Wang K, Ni X, Gu J, Lu H, Lu Y, Lu L, Dai X, Wang X.

Int Immunopharmacol. 2015 May 4. pii: S1567-5769(15)00192-7. doi: 10.1016/j.intimp.2015.04.028. [Epub ahead of print]

PMID:
25952928
14.

Tumor-associated antigen specific CD8+ T cells in hepatocellular carcinoma - a promising target for immunotherapy.

Schmidt N, Flecken T, Thimme R.

Oncoimmunology. 2014 Dec 13;3(9):e954919. eCollection 2014 Oct.

PMID:
25941604
15.

[Relationship between CD4⁺CD25(High)CD127(low) regularly T cells in the peripheral blood and tumor regression after neoadjuvant therapy in patients with rectal cancer].

Wang H, Liu H, Su W, Zhang Y, Feng Y, Lu Y.

Zhonghua Wei Chang Wai Ke Za Zhi. 2015 Apr;18(4):361-4. Chinese.

PMID:
25940180
16.

[Progress in regulatory T cells and hepatocellular carcinoma].

Jiang S, Peng D, He L.

Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2015 Apr;40(4):433-7. doi: 10.11817/j.issn.1672-7347.2015.04.016. Chinese.

17.
18.

Abnormal quantity and function of regulatory T cells in peripheral blood of patients with severe aplastic anemia.

Yan L, Fu R, Liu H, Wang H, Liu C, Wang T, Qi W, Guan J, Li L, Shao Z.

Cell Immunol. 2015 Apr 13. pii: S0008-8749(15)00080-5. doi: 10.1016/j.cellimm.2015.04.001. [Epub ahead of print]

PMID:
25906694
19.

Role of regulatory T cell in clinical outcome of traumatic brain injury.

Li M, Lin YP, Chen JL, Li H, Jiang RC, Zhang JN.

Chin Med J (Engl). 2015 Apr 20;128(8):1072-8. doi: 10.4103/0366-6999.155094.

20.

Tumor-infiltrating lymphocyte activity is enhanced in tumors with low IL-10 production in HBV-induced hepatocellular carcinoma.

Shi Y, Song Q, Hu D, Zhuang X, Yu S.

Biochem Biophys Res Commun. 2015 May 22;461(1):109-14. doi: 10.1016/j.bbrc.2015.03.177. Epub 2015 Apr 8.

PMID:
25862952
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk